July 15, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Assay measures eMTBR-tau as biomarker for tau tangle burden in Alzheimer’s diagnosis
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International Conference. Definitive diagnoses require evidence of amyloid plaques and tau neurofibrillary tangles, Alamar Biosciences said in a press release. Blood tests can measure p-tau217, which indicates amyloid
1,061 words~5 min read
